SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

August 25, 2016

-----------------

(Date of Report)

ALANCO TECHNOLOGIES, INC.

-------------------------

(Exact name of Registrant as specified in its charter)

0-9437

---------

(Commission File No.)

ARIZONA                        86-0220694

---------------------------     ---------------------------------

(State or other jurisdiction)    (IRS Employer Identification No.)

7950 E. ACOMA DRIVE, SUITE 111, SCOTTSDALE, ARIZONA  85260

-------------------------------------------------------

(Address of Principal Executive Office)       (Zip Code)

(480) 607-1010

----------------------------------------------------

(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

(  ) Written communication pursuant to Rule 425 under the Securities Act

      (17 CFR 230.425)

(  ) Soliciting material pursuant to Rule 14a-12 under the Exchange Act

     (17 CFR 240.14a-12)

(  ) Pre-commencement communications pursuant to Rule 14d-2(b) under the

 Exchange Act (17 CFR 240.14d-2(b))

(  ) Pre-commencement communications pursuant to Rule 13e-4(c) under the

Exchange Act (17 CFR 240.13e-4(c))

On August 22, 2016, the Company announced it is launching a behavioral health subsidiary.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alanco Technologies, Inc.
	By:	/s/ John A. Carlson
		Name:  John A. Carlson
		Title:    Director, President & Chief Executive Officer
Date:  August 25, 2016